Trial Profile
Amyloid Imaging in the “Italian Network for autosomal dominant Alzheimer's disease and frontotemporal lobar degeneration (ItalianDIAfN)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Mar 2016
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 10 Mar 2016 New trial record